MK-1064 | m-entrepreneurship.com

Product Name :
MK-1064

Search keywords :
MK-1064

drugId :
null

Target Vo:
Orexin receptor type 2

Target Vo Short Name :
OX2R

Moa_Name:
Orexin receptor type 2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Merck & Co Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Sleep Initiation and Maintenance Disorders

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
eIF4EBP1 Rabbit mAb manufacturer
M-CSF Rabbit mAb MedChemExpress
BNIP3L Antibody: BNIP3L Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 24 kDa, targeting to BNIP3L. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts